Mariner, LLC

Position in HCM — HUTCHMED (China) Ltd

CIK 1373442 Overland Park, KS

Position in HCM

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$163,438

+$20,168 QoQ

Shares Held

10,925

+1.6% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#27

of 54 holders

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Mariner, LLC holds $80,494,778 across 23 Drug Manufacturers - Specialty & Generic names. HCM ranks #16 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	160,869	$21,192,881
2	UTHR	UNITED THERAPEUTICS Corp	27,937	$16,566,080
3	ZTS	Zoetis Inc.	117,842	$13,930,101
4	HLN	Haleon plc	636,787	$6,374,236
5	TAK	Takeda Pharmaceutical Co Ltd	234,988	$4,351,976
6	TEVA	Teva Pharmaceutical Industries Ltd	131,941	$3,974,062
7	AMRX	Amneal Pharmaceuticals, Inc.	315,554	$3,922,336
8	RDY	Dr Reddys Laboratories Ltd	221,274	$3,064,644

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$163,438	10,925	+1.6%	Shares	Sole	2026-05-13
2025-12-31	$143,270	10,748	-25.1%	Shares	Sole	2026-02-13
2025-09-30	$225,949	14,346	-3.5%	Shares	Sole	2025-11-14
2025-06-30	$223,778	14,869	+14.7%	Shares	Sole	2025-08-14
2025-03-31	$195,053	12,969	-7.0%	Shares	Sole	2025-05-15
2024-12-31	$200,918	13,943	+2.6%	Shares	Sole	2025-02-13
2024-09-30	$265,393	13,589	+0.6%	Shares	Sole	2024-11-13
2024-06-30	$231,308	13,511	+9.3%	Shares	Sole	2024-08-13
2024-03-31	$207,580	12,356	+9.6%	Shares	Sole	2024-05-15
2023-12-31	$204,244	11,278	+12.2%	Shares	Sole	2024-02-14
2023-09-30	$170,230	10,049	-11.3%	Shares	Sole	2023-11-13
2023-03-31	$147,451	11,325	+1.8%	Shares	Sole	2023-05-15
2022-12-31	$164,427	11,125	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.